Literature DB >> 20441062

Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria.

R Omoregie1, S I Osakue, V Ihemeje, E U Omokaro, H O Ogeferet.   

Abstract

OBJECTIVE: To determine the effect of CD4 count on platelet count, prothrombin time (PT) and activated partial thromboplastin time (APTT) among HIV patients.
METHOD: Blood samples were collected from 100 subjects consisting of 70 HIV treatment naive patients and 30 HIV seronegative individuals. Platelet count, CD4 count, PT and APTT were performed on the blood samples using standard techniques. RESULT: HIV-positive patients had significantly (p < 0.001) lower CD4 and platelet counts than HIV-negative subjects. Also, PT and APTT were significantly (p < 0.001) higher in HIV patients compared with their HIV negative counterparts. Among the HIV-infected patients, platelet count did not differ significantly (p > 0.05) between those with CD4 count < 200 cells//L and those with CD4 count 2 200 cells/microL. However PT and APTT were significantly (p < 0.005 and p < 0.001 respectively) higher in HIV patients with CD4 count < 200 cell/microL. Only PT significantly correlated with CD4 count (r = 0.5406, p < 0.001) and this correlation was observed only among HIV patients with CD4 count < 200 cell/pL (r = 0.6227, p < 0.001).
CONCLUSION: HIV patients with CD4 count < 200 cell/pL have higher PT and APTT values; PT only correlated with CD4 count and endothelial activation is suggested as the possible mechanism for the coagulation defect.

Entities:  

Mesh:

Year:  2009        PMID: 20441062

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  8 in total

1.  Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status.

Authors:  R Thulasi Raman; D Manimaran; Praveen Rachakatla; K Bharathi; Tameem Afroz; Radha Sagar
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Analysis of the Coagulation Profile in Children with HIV Infection-Effect of Disease and Anti Retroviral Therapy.

Authors:  Priya Thomas; Sunita Sharma; Jagdish Chandra; Anita Nangia; Shivali Sehgal
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-05       Impact factor: 0.900

Review 3.  Coagulation Parameters in Human Immunodeficiency Virus Infected Patients: A Systematic Review and Meta-Analysis.

Authors:  Solomon Getawa; Tiruneh Adane
Journal:  AIDS Res Treat       Date:  2022-04-21

4.  Haemostatic trends in HIV-infected individuals in Yaoundé, Cameroon: a pilot study.

Authors:  Larissa Tene; Claude T Tagny; Annick Mintya-Ndoumba; Victor N Fossi; Dora Mbanya
Journal:  Blood Coagul Fibrinolysis       Date:  2014-07       Impact factor: 1.276

5.  18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine.

Authors:  Frances Zenón; Inmaculada Jorge; Ailed Cruz; Erick Suárez; Annabell C Segarra; Jesús Vázquez; Loyda M Meléndez; Horacio Serrano
Journal:  Proteomics Clin Appl       Date:  2015-11-19       Impact factor: 3.494

Review 6.  Interaction of the Human Contact System with Pathogens-An Update.

Authors:  Sonja Oehmcke-Hecht; Juliane Köhler
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

7.  Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Authors:  Masresha Seyoum; Bamlaku Enawgaw; Zegeye Getaneh; Getabalew Engidaye; Fikir Asrie; Mulugeta Melku
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

8.  Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study.

Authors:  Marilza Campos de Magalhães; Juan Camilo Sánchez-Arcila; Ana Carolina de Brito Lyra; Luiz Felipe Boufleur Long; Isabelle Vasconcellos de Souza; Fernando Raphael de Almeida Ferry; Adilson José de Almeida; Soniza Vieira Alves-Leon
Journal:  PLoS One       Date:  2020-02-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.